Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| STAAR SURGIC | STAA | 10.98% |
| DTS INC | DTSI | 6.89% |
| ANIKA THERAP | ANIK | 6.04% |
| LUMOS NETWOR | LMOS | 5.70% |
| INSTEEL IND | IIIN | 5.28% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Leading cigarette maker, Reynolds American Inc. (RAI - Analyst Report) delivered adjusted earnings of 79 cents (excluding a one-time charge of 5 cents) per share in the third quarter of fiscal year 2012, up 6.8% from the prior-year quarter earnings of 74 cents.
Benefits from improved pricing and volume gains for moist snuff products offset decline in cigarette volumes and marketing expenses. The results were in-line with the Zacks Consensus Estimate.
Revenues and Operating Margin
Reynolds’ net sales in the reported quarter declined 3.8% year over year to $2.12 billion due to declining cigarette volumes. Quarterly net sales also missed the Zacks Consensus Estimate of $2.19 billion.
Governmental actions that prohibit the use of tobacco products, along with diminishing social acceptance of smoking, are adversely impacting Reynolds’ volume.
Adjusted operating income increased 1.7% to $764 million while adjusted operating margin increased 2.0 percentage points to 36.1%.
Segment Details
RJR Tobacco: This is Reynolds’ largest operating segment comprising operations of R. J. Reynolds Tobacco Company, a subsidiary of Reynolds American and the second-largest U.S. tobacco company. It includes popular cigarette brands like Camel, Winston, Kool, Doral, Salem and Pall Mall. Segment revenue declined 6.1% to $1.77 billion in the third quarter.
Volumes declined 6.9% in the segment compared to a 2.7% decline for the industry due to losses on shipments and increased promotional activity by competitors. RJR Tobacco’s market share declined 1.0% year over year to 26.4% in the third quarter.
The premium Camel brand held a market share of 8.5% in the third quarter, almost flat year over year. However, it is pressurized by a weak economy and promotional activity by competitors. Value brand Pall Mall held a market share of 8.7%, up 0.1 percentage point.
Compared with the year-ago quarter, the segment’s adjusted operating income declined 3.9% to $606 million, with cigarette volume declines and increased promotional costs more than offsetting pricing gains and productivity benefits. Adjusted operating margin expanded 0.7 percentage points to 34.2%.
American Snuff: This segment comprises operations of American Snuff Company, a wholly- owned subsidiary of Reynolds American and the nation’s second-largest manufacturer of smokeless tobacco products. It sells some of the largest selling moist snuff brands like Grizzly and Kodiak. Segment revenue increased 6.7% to $174 million in the third quarter.
Volumes increased 6.6% in the segment compared to the 5% volume gain for the moist-snuff industry. The moist snuff market share increased 0.9 percentage points year over year to 32.2% in the quarter. Grizzly brand volumes grew 7.8% while market share expanded 1.2 percentage points to 28.8% benefiting from the company’s investment in brand building programs. Grizzly is the best selling moist snuff brand in the U.S.
Adjusted operating income increased 11.4% to $100 million, driven by volume and market share gains for the popular Grizzly brand. Adjusted operating margin increased 2.4 percentage points year over year to 57.4%. Profit margins on moist snuff products are generally higher than on cigarette products.
Santa Fe: This segment comprises operations of Santa Fe Natural Tobacco Company, a wholly-owned subsidiary of Reynolds American and manufactures Natural American Spirit cigarettes and other additive-free tobacco products. Segment revenue increased 14.7% to $125 million in the third quarter.
Volumes increased 13.9% in the segment. Natural American Spirit’s market share expanded 0.2 percentage points to 1.2%.
Adjusted operating income increased 35.3% to $63 million, driven by pricing and volume gains for its super premium brand Natural American Spirit. Adjusted operating margin increased 7.4 percentage point year over year to 50.4%.
Other Financial Update
In the quarter, Reynolds American repurchased 6.5 million shares for $300 million in the third quarter.
Guidance
Following the third quarter results, Reynolds American reaffirmed its fiscal 2012 adjusted earnings guidance in the range of $2.91 to $3.01 per share. The Zacks Consensus Estimate stands at $2.96 per share.
Competitor Philip Morris International Inc (PM - Analyst Report), which reported its third quarter results on October 18, beat the bottom line expectations. However, it lagged the top-line expectations.
Currently, the stock carries a Zacks #4 Rank (a short-term Sell rating). We have a Neutral recommendation on Reynolds American over the long term.
Get the full Analyst Report on RAI - FREE
Get the full Analyst Report on PM - FREE